These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36389185)

  • 41. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutrophil CD64 expression levels in IGRA-positive individuals distinguish latent tuberculosis from active disease.
    Corrêa RDS; Rodrigues LS; Pereira LHL; Nogueira OC; Leung J; Sousa MDS; Hacker MA; Siqueira HR; Capone D; Alves RLR; Pessolani MCV; Schmitz V; Pereira GMB
    Mem Inst Oswaldo Cruz; 2019; 114():e180579. PubMed ID: 30970080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
    Kim JY; Kang YA; Park JH; Cha HH; Jeon NY; Lee SW; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2020 Jul; 26(7):928-934. PubMed ID: 31730906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of latent Mycobacterium tuberculosis infection: tuberculin test versus interferon-gamma release.
    Ferreira TF; Matsuoka Pda F; Santos AM; Caldas Ade J
    Rev Soc Bras Med Trop; 2015; 48(6):724-30. PubMed ID: 26676497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.
    Faurholt-Jepsen D; Aabye MG; Jensen AV; Range N; Praygod G; Jeremiah K; Changalucha J; Faurholt-Jepsen M; Jensen L; Jensen SM; Krarup H; Ravn P; Friis H; Andersen AB
    Scand J Infect Dis; 2014 May; 46(5):384-91. PubMed ID: 24621055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary miRNA-29a-3p levels are associated with metabolic parameters via regulation of IGF1 in patients with metabolic syndrome.
    Lin X; Luo C; He D; Matro E; Chen Q; Li H; Zhou J
    Biomed Rep; 2019 Apr; 10(4):250-258. PubMed ID: 30972221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a lateral flow assay-based IFN-γ release assay as a point-of-care test for the diagnosis of latent tuberculosis infection.
    Lee HH; Choi DH; Kim JR; Kim YG; Jo KW; Shim TS
    Clin Rheumatol; 2021 Sep; 40(9):3773-3781. PubMed ID: 33666781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Detection of Latent Tuberculosis Infection in Egyptian Pediatric Household Contacts.
    El-Sheikh N; Mousa NO; Osman A; Tawfeik AM; Taha BA; Mahran H; Saleh AM; El-Shiekh I; Amin W; Elrefaei M
    Int J Infect Dis; 2021 Aug; 109():223-229. PubMed ID: 34271200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosis.
    Gao SH; Chen CG; Zhuang CB; Zeng YL; Zeng ZZ; Wen PH; Yu YM; Ming L; Zhao JW
    J Clin Lab Anal; 2021 Aug; 35(8):e23871. PubMed ID: 34106501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis.
    Kim J; Park H; Park SB; Lee EJ; Je MA; Ahn E; Sim B; Lee J; Jin H; Lee KE; Cho SN; Kang YA; Lee H; Kim S; Kim J
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expressions of miR-29a, TNF-Α and Vascular Endothelial Growth Factor in Peripheral Blood of Pulmonary Tuberculosis Patients and Their Clinical Significance.
    Li Z; Li C; Bao R; Liu Z
    Iran J Public Health; 2020 Sep; 49(9):1683-1691. PubMed ID: 33643943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
    Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
    APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10.
    Ghanaie RM; Karimi A; Azimi L; James S; Nasehi M; Mishkar AP; Sheikhi M; Fallah F; Tabatabaei SR; Hoseini-Alfatemi SM
    BMC Pediatr; 2021 Feb; 21(1):76. PubMed ID: 33573613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.